EVOK - Evoke Pharma GAAP EPS of -$0.60 beats by $0.06 revenue of $0.83M beats by $0.26M
- Evoke Pharma press release ( NASDAQ: EVOK ): Q3 GAAP EPS of -$0.60 beats by $0.06 .
- Revenue of $0.83M (-10.8% Y/Y) beats by $0.26M .
- 80% increase in GIMOTI ® net revenue over Q2 2022
- 56% increase of GIMOTI prescription fills in Q3 compared to Q2
- 13% increase of new prescribers of GIMOTI over Q2
For further details see:
Evoke Pharma GAAP EPS of -$0.60 beats by $0.06, revenue of $0.83M beats by $0.26M